{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T03:32:52Z","timestamp":1771903972729,"version":"3.50.1"},"reference-count":181,"publisher":"Baishideng Publishing Group Inc.","issue":"29","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2016]]},"DOI":"10.3748\/wjg.v22.i29.6638","type":"journal-article","created":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T12:33:27Z","timestamp":1469795607000},"page":"6638","source":"Crossref","is-referenced-by-count":53,"title":["Use of rifaximin in gastrointestinal and liver diseases"],"prefix":"10.3748","volume":"22","author":[{"given":"Rani H","family":"Shayto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Abou Mrad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ala I","family":"Sharara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1159\/000089776"},{"key":"ref2","unstructured":"Baker DE. Rifaximin: a nonabsorbed oral antibiotic. Rev Gastroenterol Disord 2005;5:19-30."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13434"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1159\/000081990"},{"key":"ref5","unstructured":"Descombe JJ, Dubourg D, Picard M, Palazzini E. Pharmacokinetic study of rifaximin after oral administration in healthy volunteers. Int J Clin Pharmacol Res 1994;14:51-56."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12735"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Jiang ZD, Ke S, Palazzini E, Riopel L, Dupont H. In vitro activity and fecal concentration of rifaximin after oral administration. Antimicrob Agents Chemother 2000;44:2205-2206.","DOI":"10.1128\/AAC.44.8.2205-2206.2000"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1H395"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Robins GW, Wellington K. Rifaximin: a review of its use in the management of traveller’s diarrhoea. Drugs 2005;65:1697-1713.","DOI":"10.2165\/00003495-200565120-00011"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00161-10"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1159\/000081991"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2011.546347"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068550"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.11.061"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, Whitehead WE, Janssens J, Funch-Jensen P, Corazziari E. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993;38:1569-1580.","DOI":"10.1007\/BF01303162"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Simrén M, Abrahamsson H, Svedlund J, Björnsson ES. Quality of life in patients with irritable bowel syndrome seen in referral centers versus primary care: the impact of gender and predominant bowel pattern. Scand J Gastroenterol 2001;36:545-552.","DOI":"10.1080\/003655201750153476"},{"key":"ref17","unstructured":"Dean BB, Aguilar D, Barghout V, Kahler KH, Frech F, Groves D, Ofman JJ. Impairment in work productivity and health-related quality of life in patients with IBS. Am J Manag Care 2005;11:S17-S26."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02463.x"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Longstreth GF. Irritable bowel syndrome: a multibillion-dollar problem. Gastroenterology 1995;109:2029-2031.","DOI":"10.1016\/0016-5085(95)90773-4"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Talley NJ, Gabriel SE, Harmsen WS, Zinsmeister AR, Evans RW. Medical costs in community subjects with irritable bowel syndrome. Gastroenterology 1995;109:1736-1741.","DOI":"10.1016\/0016-5085(95)90738-6"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S93698"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Simrén M, Castedal M, Svedlund J, Abrahamsson H, Björnsson E. Abnormal propagation pattern of duodenal pressure waves in the irritable bowel syndrome (IBS) [correction of (IBD)]. Dig Dis Sci 2000;45:2151-2161.","DOI":"10.1023\/A:1010770302403"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Kumar D, Wingate DL. The irritable bowel syndrome: a paroxysmal motor disorder. Lancet 1985;2:973-977.","DOI":"10.1016\/S0140-6736(85)90525-2"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Schmidt T, Hackelsberger N, Widmer R, Meisel C, Pfeiffer A, Kaess H. Ambulatory 24-hour jejunal motility in diarrhea-predominant irritable bowel syndrome. Scand J Gastroenterol 1996;31:581-589.","DOI":"10.3109\/00365529609009131"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.251"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03804.x"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Caldarella MP, Serra J, Azpiroz F, Malagelada JR. Prokinetic effects in patients with intestinal gas retention. Gastroenterology 2002;122:1748-1755.","DOI":"10.1053\/gast.2002.33658"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Whitehead WE, Holtkotter B, Enck P, Hoelzl R, Holmes KD, Anthony J, Shabsin HS, Schuster MM. Tolerance for rectosigmoid distention in irritable bowel syndrome. Gastroenterology 1990;98:1187-1192.","DOI":"10.1016\/0016-5085(90)90332-U"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Bouin M, Plourde V, Boivin M, Riberdy M, Lupien F, Laganière M, Verrier P, Poitras P. Rectal distention testing in patients with irritable bowel syndrome: sensitivity, specificity, and predictive values of pain sensory thresholds. Gastroenterology 2002;122:1771-1777.","DOI":"10.1053\/gast.2002.33601"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-005-1766-x"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-005-1748-z"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Cook IJ, van Eeden A, Collins SM. Patients with irritable bowel syndrome have greater pain tolerance than normal subjects. Gastroenterology 1987;93:727-733.","DOI":"10.1016\/0016-5085(87)90434-3"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00414.x"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Wilder-Smith CH, Robert-Yap J. Abnormal endogenous pain modulation and somatic and visceral hypersensitivity in female patients with irritable bowel syndrome. World J Gastroenterol 2007;13:3699-3704.","DOI":"10.3748\/wjg.v13.i27.3699"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.10.020"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.117390"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.07.015"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197509112931103"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Serra J, Azpiroz F, Malagelada JR. Impaired transit and tolerance of intestinal gas in the irritable bowel syndrome. Gut 2001;48:14-19.","DOI":"10.1136\/gut.48.1.14"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Serra J, Salvioli B, Azpiroz F, Malagelada JR. Lipid-induced intestinal gas retention in irritable bowel syndrome. Gastroenterology 2002;123:700-706.","DOI":"10.1053\/gast.2002.35394"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejcn.1602367"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Simrén M, M\u00e5nsson A, Langkilde AM, Svedlund J, Abrahamsson H, Bengtsson U, Björnsson ES. Food-related gastrointestinal symptoms in the irritable bowel syndrome. Digestion 2001;63:108-115.","DOI":"10.1159\/000051878"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.037697"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1080\/00365520510015593"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Jun DW, Lee OY, Yoon HJ, Lee SH, Lee HL, Choi HS, Yoon BC, Lee MH, Lee DH, Cho SH. Food intolerance and skin prick test in treated and untreated irritable bowel syndrome. World J Gastroenterol 2006;12:2382-2387.","DOI":"10.3748\/wjg.v12.i15.2382"},{"key":"ref46","unstructured":"Zwetchkenbaum J, Burakoff R. The irritable bowel syndrome and food hypersensitivity. Ann Allergy 1988;61:47-49."},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02506.x"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2008.02.058"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07476.x"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2009.02.023"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Nelis GF, Vermeeren MA, Jansen W. Role of fructose-sorbitol malabsorption in the irritable bowel syndrome. Gastroenterology 1990;99:1016-1020.","DOI":"10.1016\/0016-5085(90)90621-7"},{"key":"ref52","unstructured":"Fernández-Ba\u00f1ares F, Esteve-Pardo M, de Leon R, Humbert P, Cabré E, Llovet JM, Gassull MA. Sugar malabsorption in functional bowel disease: clinical implications. Am J Gastroenterol 1993;88:2044-2050."},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Vesa TH, Seppo LM, Marteau PR, Sahi T, Korpela R. Role of irritable bowel syndrome in subjective lactose intolerance. Am J Clin Nutr 1998;67:710-715.","DOI":"10.1093\/ajcn\/67.4.710"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06581-3"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.188"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.01.049"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Saito YA, Petersen GM, Locke GR, Talley NJ. The genetics of irritable bowel syndrome. Clin Gastroenterol Hepatol 2005;3:1057-1065.","DOI":"10.1016\/S1542-3565(05)00184-9"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Levy RL, Jones KR, Whitehead WE, Feld SI, Talley NJ, Corey LA. Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology. Gastroenterology 2001;121:799-804.","DOI":"10.1053\/gast.2001.27995"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03326.x"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.035451"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.440_j.x"},{"key":"ref62","doi-asserted-by":"crossref","unstructured":"Locke GR, Weaver AL, Melton LJ, Talley NJ. Psychosocial factors are linked to functional gastrointestinal disorders: a population based nested case-control study. Am J Gastroenterol 2004;99:350-357.","DOI":"10.1111\/j.1572-0241.2004.04043.x"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.01.032"},{"key":"ref64","unstructured":"Solmaz M, Kavuk I, Sayar K. Psychological factors in the irritable bowel syndrome. Eur J Med Res 2003;8:549-556."},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2007.08.029"},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"Drossman DA, Leserman J, Nachman G, Li ZM, Gluck H, Toomey TC, Mitchell CM. Sexual and physical abuse in women with functional or organic gastrointestinal disorders. Ann Intern Med 1990;113:828-833.","DOI":"10.7326\/0003-4819-113-11-828"},{"key":"ref67","doi-asserted-by":"crossref","unstructured":"Talley NJ, Boyce PM, Jones M. Is the association between irritable bowel syndrome and abuse explained by neuroticism? A population based study. Gut 1998;42:47-53.","DOI":"10.1136\/gut.42.1.47"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1159\/000087722"},{"key":"ref69","doi-asserted-by":"crossref","unstructured":"Sagami Y, Shimada Y, Tayama J, Nomura T, Satake M, Endo Y, Shoji T, Karahashi K, Hongo M, Fukudo S. Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome. Gut 2004;53:958-964.","DOI":"10.1136\/gut.2003.018911"},{"key":"ref70","doi-asserted-by":"crossref","unstructured":"Fukudo S, Nomura T, Hongo M. Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome. Gut 1998;42:845-849.","DOI":"10.1136\/gut.42.6.845"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.01.046"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.37059"},{"key":"ref73","doi-asserted-by":"crossref","unstructured":"Chadwick VS, Chen W, Shu D, Paulus B, Bethwaite P, Tie A, Wilson I. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002;122:1778-1783.","DOI":"10.1053\/gast.2002.33579"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.100594"},{"key":"ref75","doi-asserted-by":"crossref","unstructured":"Barbara G, Stanghellini V, De Giorgio R, Cremon C, Cottrell GS, Santini D, Pasquinelli G, Morselli-Labate AM, Grady EF, Bunnett NW. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004;126:693-702.","DOI":"10.1053\/j.gastro.2003.11.055"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.11.033"},{"key":"ref77","unstructured":"Bueno L. Protease activated receptor 2: a new target for IBS treatment. Eur Rev Med Pharmacol Sci 2008;12 Suppl 1:95-102."},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.140210"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.021154"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.05.053"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.102"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2007.00988.x"},{"key":"ref83","doi-asserted-by":"crossref","unstructured":"Dunlop SP, Jenkins D, Neal KR, Spiller RC. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology 2003;125:1651-1659.","DOI":"10.1053\/j.gastro.2003.09.028"},{"key":"ref84","doi-asserted-by":"crossref","unstructured":"Mättö J, Maunuksela L, Kajander K, Palva A, Korpela R, Kassinen A, Saarela M. Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome--a longitudinal study in IBS and control subjects. FEMS Immunol Med Microbiol 2005;43:213-222.","DOI":"10.1016\/j.femsim.2004.08.009"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-009-0934-x"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.04.005"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-9-95"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-010-1276-4"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2009.06.031"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00458.x"},{"key":"ref91","doi-asserted-by":"crossref","unstructured":"Pimentel M, Park S, Mirocha J, Kane SV, Kong Y. The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial. Ann Intern Med 2006;145:557-563.","DOI":"10.7326\/0003-4819-145-8-200610170-00004"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1004409"},{"key":"ref93","unstructured":"Lembo A, Pimentel M, Rao SS. Efficacy and safety of repeat treatment with rifaximin for diarrhea-predominant irritable bowel syndrome (IBS-D): results of the TARGET 3 study Presented at: American College of Gastroenterology (ACG); 2014;Annual Scientific Meeting; October 17-22; Philadelphia, PA, 2014."},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12087"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.355"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07234.x"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2015.30.6.757"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01072.x"},{"key":"ref99","doi-asserted-by":"crossref","unstructured":"Davidson GP, Robb TA, Kirubakaran CP. Bacterial contamination of the small intestine as an important cause of chronic diarrhea and abdominal pain: diagnosis by breath hydrogen test. Pediatrics 1984;74:229-235.","DOI":"10.1542\/peds.74.2.229"},{"key":"ref100","doi-asserted-by":"crossref","unstructured":"Pimentel M, Mayer AG, Park S, Chow EJ, Hasan A, Kong Y. Methane production during lactulose breath test is associated with gastrointestinal disease presentation. Dig Dis Sci 2003;48:86-92.","DOI":"10.1023\/A:1021738515885"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2016.32"},{"key":"ref102","doi-asserted-by":"crossref","unstructured":"DuPont HL, Capsuto EG. Persistent diarrhea in travelers. Clin Infect Dis 1996;22:124-128.","DOI":"10.1093\/clinids\/22.1.124"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199306243282507"},{"key":"ref104","doi-asserted-by":"crossref","unstructured":"Steffen R. Epidemiologic studies of travelers’ diarrhea, severe gastrointestinal infections, and cholera. Rev Infect Dis 1986;8 Suppl 2:S122-S130.","DOI":"10.1093\/clinids\/8.Supplement_2.S122"},{"key":"ref105","doi-asserted-by":"crossref","unstructured":"Taylor DN, Bourgeois AL, Ericsson CD, Steffen R, Jiang ZD, Halpern J, Haake R, Dupont HL. A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers’ diarrhea. Am J Trop Med Hyg 2006;74:1060-1066.","DOI":"10.4269\/ajtmh.2006.74.1060"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1086\/323814"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2007.02.004"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1111\/j.1708-8305.2009.00300.x"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(13)70221-4"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.1111\/j.1708-8305.2010.00462.x"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.1111\/j.1708-8305.2011.00549.x"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.1111\/j.1708-8305.2009.00385.x"},{"key":"ref113","doi-asserted-by":"crossref","unstructured":"Peralta S, Cottone C, Doveri T, Almasio PL, Craxi A. Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: experience with Rifaximin. World J Gastroenterol 2009;15:2628-2631.","DOI":"10.3748\/wjg.15.2628"},{"key":"ref114","unstructured":"Cuoco L, Salvagnini M. Small intestine bacterial overgrowth in irritable bowel syndrome: a retrospective study with rifaximin. Minerva Gastroenterol Dietol 2006;52:89-95."},{"key":"ref115","doi-asserted-by":"crossref","unstructured":"Lauritano EC, Gabrielli M, Scarpellini E, Lupascu A, Novi M, Sottili S, Vitale G, Cesario V, Serricchio M, Cammarota G. Small intestinal bacterial overgrowth recurrence after antibiotic therapy. Am J Gastroenterol 2008;103:2031-2035.","DOI":"10.1111\/j.1572-0241.2008.02030.x"},{"key":"ref116","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02516.x"},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03259.x"},{"key":"ref118","unstructured":"Zhang Y, Feng Y, Cao B, Tian Q. Effects of SIBO and rifaximin therapy on MHE caused by hepatic cirrhosis. Int J Clin Exp Med 2015;8:2954-2957."},{"key":"ref119","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-014-0049-x"},{"key":"ref120","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27210"},{"key":"ref121","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.219"},{"key":"ref122","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-159-8-201310150-02008"},{"key":"ref123","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907893"},{"key":"ref124","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04808.x"},{"key":"ref125","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2013.12.021"},{"key":"ref126","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12993"},{"key":"ref127","doi-asserted-by":"publisher","DOI":"10.4103\/1319-3767.136975"},{"key":"ref128","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-016-1205-8"},{"key":"ref129","doi-asserted-by":"crossref","unstructured":"Painter NS, Burkitt DP. Diverticular disease of the colon, a 20th century problem. Clin Gastroenterol 1975;4:3-21.","DOI":"10.1016\/S0300-5089(21)00094-8"},{"key":"ref130","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.10.035"},{"key":"ref131","doi-asserted-by":"crossref","unstructured":"Parks TG. Natural history of diverticular disease of the colon. Clin Gastroenterol 1975;4:53-69.","DOI":"10.1016\/S0300-5089(21)00097-3"},{"key":"ref132","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2013.06.020"},{"key":"ref133","doi-asserted-by":"crossref","unstructured":"Shayto R, Hanna K, Ziyadeh N, Chehab H, Chalhoub JM, Harb AH, Sarkis FS, Soweid A, Barada K, Mourad F. The Natural History of Incidental Colonic Diverticulosis on Screening Colonoscopy: A Prospective Cohort Study Presented at: Digestive Disease Week (DDW); 2016;Gastroenterology, 2016: 1411.","DOI":"10.1016\/S0016-5085(16)31080-0"},{"key":"ref134","doi-asserted-by":"crossref","unstructured":"Commane DM, Arasaradnam RP, Mills S, Mathers JC, Bradburn M. Diet, ageing and genetic factors in the pathogenesis of diverticular disease. World J Gastroenterol 2009;15:2479-2488.","DOI":"10.3748\/wjg.15.2479"},{"key":"ref135","doi-asserted-by":"crossref","unstructured":"Finegold SM, Attebery HR, Sutter VL. Effect of diet on human fecal flora: comparison of Japanese and American diets. Am J Clin Nutr 1974;27:1456-1469.","DOI":"10.1093\/ajcn\/27.12.1456"},{"key":"ref136","doi-asserted-by":"crossref","unstructured":"Segal I, Walker AR, Wadee A. Persistent low prevalence of Western digestive diseases in Africa: confounding aetiological factors. Gut 2001;48:730-732.","DOI":"10.1136\/gut.48.5.730"},{"key":"ref137","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04606.x"},{"key":"ref138","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2012.09.006"},{"key":"ref139","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e318188adc1"},{"key":"ref140","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.11.059"},{"key":"ref141","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2012.152"},{"key":"ref142","doi-asserted-by":"publisher","DOI":"10.1086\/649923"},{"key":"ref143","doi-asserted-by":"crossref","unstructured":"Nikfar S, Mirfazaelian H, Abdollahi M. Efficacy and tolerability of immunoregulators and antibiotics in fistulizing Crohn’s disease: a systematic review and meta-analysis of placebo-controlled trials. Curr Pharm Des 2010;16:3684-3698.","DOI":"10.2174\/138161210794079236"},{"key":"ref144","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2006.12.012"},{"key":"ref145","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-007-9760-1"},{"key":"ref146","doi-asserted-by":"crossref","unstructured":"Fiorucci S, Distrutti E, Mencarelli A, Barbanti M, Palazzini E, Morelli A. Inhibition of intestinal bacterial translocation with rifaximin modulates lamina propria monocytic cells reactivity and protects against inflammation in a rodent model of colitis. Digestion 2002;66:246-256.","DOI":"10.1159\/000068362"},{"key":"ref147","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq345"},{"key":"ref148","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.110.170225"},{"key":"ref149","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2010.08.022"},{"key":"ref150","doi-asserted-by":"publisher","DOI":"10.1185\/030079905X53252"},{"key":"ref151","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-009-1111-y"},{"key":"ref152","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.02879.x"},{"key":"ref153","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.11.032"},{"key":"ref154","doi-asserted-by":"publisher","DOI":"10.1097\/01.MIB.0000215092.85116.6c"},{"key":"ref155","doi-asserted-by":"crossref","unstructured":"Gionchetti P, Rizzello F, Ferrieri A, Venturi A, Brignola C, Ferretti M, Peruzzo S, Miglioli M, Campieri M. Rifaximin in patients with moderate or severe ulcerative colitis refractory to steroid-treatment: a double-blind, placebo-controlled trial. Dig Dis Sci 1999;44:1220-1221.","DOI":"10.1023\/A:1026648812439"},{"key":"ref156","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-8-26"},{"key":"ref157","doi-asserted-by":"crossref","unstructured":"Conn HO. Spontaneous peritonitis and bacteremia in laennec’s cirrhosis caused by enteric organisms. A RELATIVELY COMMON BUT RARELY RECOGNIZED SYNDROME. Ann Intern Med 1964;60:568-580.","DOI":"10.7326\/0003-4819-60-4-568"},{"key":"ref158","doi-asserted-by":"crossref","unstructured":"Navasa M, Follo A, Llovet JM, Clemente G, Vargas V, Rimola A, Marco F, Guarner C, Forné M, Planas R. Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis. Gastroenterology 1996;111:1011-1017.","DOI":"10.1016\/S0016-5085(96)70069-0"},{"key":"ref159","doi-asserted-by":"crossref","unstructured":"Guarner C, Runyon BA, Young S, Heck M, Sheikh MY. Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites. J Hepatol 1997;26:1372-1378.","DOI":"10.1016\/S0168-8278(97)80474-6"},{"key":"ref160","doi-asserted-by":"crossref","unstructured":"Runyon BA, Squier S, Borzio M. Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis. J Hepatol 1994;21:792-796.","DOI":"10.1016\/S0168-8278(94)80241-6"},{"key":"ref161","doi-asserted-by":"crossref","unstructured":"Madrid AM, Cumsille F, Defilippi C. Altered small bowel motility in patients with liver cirrhosis depends on severity of liver disease. Dig Dis Sci 1997;42:738-742.","DOI":"10.1023\/A:1018899611006"},{"key":"ref162","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.558"},{"key":"ref163","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e3182506dbb"},{"key":"ref164","doi-asserted-by":"publisher","DOI":"10.5152\/tjg.2015.7782"},{"key":"ref165","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0093909"},{"key":"ref166","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.03958.x"},{"key":"ref167","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12070"},{"key":"ref168","doi-asserted-by":"publisher","DOI":"10.1086\/651706"},{"key":"ref169","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.4"},{"key":"ref170","unstructured":"Boero M, Berti E, Morgando A, Verme G. Treatment for colitis caused by Clostridium difficile: results of a randomized open study of rifaximine vs. vancomycin. Microbiol Medica 1990;5:74-77."},{"key":"ref171","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/106978"},{"key":"ref172","doi-asserted-by":"publisher","DOI":"10.1086\/511870"},{"key":"ref173","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr377"},{"key":"ref174","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12111"},{"key":"ref175","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00548-13"},{"key":"ref176","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2004.00997.x"},{"key":"ref177","doi-asserted-by":"crossref","unstructured":"Marchese A, Salerno A, Pesce A, Debbia EA, Schito GC. In vitro activity of rifaximin, metronidazole and vancomycin against Clostridium difficile and the rate of selection of spontaneously resistant mutants against representative anaerobic and aerobic bacteria, including ammonia-producing species. Chemotherapy 2000;46:253-266.","DOI":"10.1159\/000007297"},{"key":"ref178","doi-asserted-by":"crossref","unstructured":"Brigidi P, Swennen E, Rizzello F, Bozzolasco M, Matteuzzi D. Effects of rifaximin administration on the intestinal microbiota in patients with ulcerative colitis. J Chemother 2002;14:290-295.","DOI":"10.1179\/joc.2002.14.3.290"},{"key":"ref179","unstructured":"De Leo C, Eftimiadi C, Schito GC. Rapid disappearance from the intestinal tract of bacteria resistant to rifaximin. Drugs Exp Clin Res 1986;12:979-981."},{"key":"ref180","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.1.212-216.2001"},{"key":"ref181","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00739-10"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v22\/i29\/6638.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T07:48:47Z","timestamp":1656920927000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v22\/i29\/6638.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":181,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.v22.i29.6638","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}